Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Movement Disorders

• Publication date

  2011-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/mds.23295PMID 21412832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical correlates of similar pathologies in parkinsonian syndromes

  2011cited by this paper
• Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy

  2009cited by this paper
• Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.

  2009influential reference
• Different Tau Pathology Pattern in Two Clinical Phenotypes of Progressive Supranuclear Palsy

  2008influential reference
• MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.

  2008cited by this paper
• Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson’s disease

  2007cited by this paper
• MR imaging of brainstem atrophy in progressive supranuclear palsy

  2007cited by this paper
• Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.

  2007influential reference
• Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.

  2006cited by this paper
• Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.

  2006cited by this paper
• Staging disease severity in movement disorder tauopathies: Brain atrophy separates progressive supranuclear palsy from corticobasal degeneration

  2005cited by this paper
• Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.

  2005cited by this paper
• Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

  2005cited by this paper
• Subcortical dementia revisited: Similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA)

  2005cited by this paper
• Cognitive bedside assessment in atypical parkinsonian syndromes

  2005cited by this paper
• A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.

  2005cited by this paper
• Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy

  2004influential reference
• Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy

  2004cited by this paper
• Clinicopathological Staging of Frontotemporal Dementia Severity: Correlation with Regional Atrophy

  2004cited by this paper
• Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration

  2004cited by this paper
• Identifying severely atrophic cortical subregions in Alzheimer's disease.

  2003cited by this paper
• Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy

  2001cited by this paper
• Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.

  2001cited by this paper
• Corticobasal syndrome with tau pathology

  2001cited by this paper
• A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy.

  2000cited by this paper
• Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.

  2000cited by this paper
• Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy.

  2000cited by this paper
• Regional brain atrophy in progressive supranuclear palsy and Lewy body disease

  2000cited by this paper
• Spatial attention and neglect: parietal, frontal and cingulate contributions to the mental representation and attentional targeting of salient extrapersonal events.

  1999cited by this paper
• Specific temporoparietal gyral atrophy reflects the pattern of language dissolution in Alzheimer's disease.

  1999cited by this paper
• The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.

  1999cited by this paper
• Movement Disorders

  1998cited by this paper
• The neuropsychology of progressive supranuclear palsy

  1998cited by this paper
• Regional specificity of brain atrophy in Huntington's disease.

  1998cited by this paper
• The cerebral cortex is damaged in chronic alcoholics.

  1997cited by this paper
• Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration.

  1997cited by this paper
• Topography of brain atrophy during normal aging and Alzheimer's disease.

  1996cited by this paper
• Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders

  1996influential reference
• The nucleus raphe interpositus in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

  1996cited by this paper
• Mesencephalic cholinergic nuclei in progressive supranuclear palsy

  1991cited by this paper
• Frontal lobe function in progressive supranuclear palsy.

  1990influential reference
• The `subcortical dementia' of progressive supranuclear palsy

  1974cited by this paper

• Cholinergic substrates of gait and postural impairments in Progressive Supranuclear Palsy

  2026cites this paper
• Annual percentage change of MR Parkinsonism index in progressive supranuclear palsy: a feasibility study

  2025cites this paper
• Slowing of Frontal β Oscillations in Atypical Parkinsonism

  2023cites this paper
• Striatal and thalamic automatic segmentation, morphology, and clinical correlates in Parkinsonism: Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.

  2023cites this paper
• Differentiating between common PSP phenotypes using structural MRI: a machine learning study

  2023cites this paper
• Neuroimaging correlates of postural instability in Progressive Supranuclear Palsy.

  2023cites this paper
• Simple and clear differentiation of spinocerebellar degenerations: Overview of macroscopic and low‐power view findings

  2022cites this paper
• Slowing of Frontocentral Beta Oscillations in Atypical Parkinsonism

  2022influential citation
• 18F-FDG PET/CT and 99mTc-TRODAT Scan Findings in the Variants of Progressive Supranuclear Palsy and Correlation With Clinical Findings

  2022influential citation
• Diagnosing Subtypes of Progressive Supranuclear Palsy: Can 18F-FDG PET/CT Imaging Guide Our Way?

  2022cites this paper
• The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)

  2022cites this paper
• The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome—A Pilot Study

  2021influential citation
• Diagnostic potential of automated tractography in progressive supranuclear palsy variants.

  2020cites this paper
• Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)

  2020cites this paper
• Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy

  2020influential citation
• Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants

  2019cites this paper
• Language impairment in progressive supranuclear palsy and corticobasal syndrome

  2019cites this paper
• PET markers of tau and neuroinflammation are co-localized in progressive supranuclear palsy

  2019influential citation
• Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders

  2019cites this paper
• Track density imaging in progressive supranuclear palsy: A pilot study

  2018cites this paper
• Prospective Characterization of Cognitive Function in Typical and ‘Brainstem Predominant’Progressive Supranuclear Palsy Phenotypes

  2018cites this paper
• Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy

  2017cites this paper
• Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.

  2017cites this paper
• [18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy

  2017cites this paper
• Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

  2017cites this paper
• Brain gray matter abnormalities in progressive supranuclear palsy revisited

  2017cites this paper
• An autopsy confirmed case of progressive supranuclear palsy with predominant cerebellar ataxia

  2016cites this paper
• Progressive Supranuclear Palsy and Dementia

  2015cites this paper
• Directed Network Motifs in Alzheimer’s Disease and Mild Cognitive Impairment

  2015cites this paper
• Bilateral Pedunculopontine Nucleus Stimulation for Progressive Supranuclear Palsy

  2015cites this paper
• Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study

  2014cites this paper
• Directed Progression Brain Networks in Alzheimer's Disease: Properties and Classification

  2014cites this paper
• Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy

  2014cites this paper
• The Diagnostic Evaluation of a Patient With Dementia

  2013cites this paper
• Intrinsic connectivity network disruption in progressive supranuclear palsy

  2013cites this paper
• Voxelwise meta-analysis of white matter abnormalities in progressive supranuclear palsy

  2013influential citation
• Transcranial brain sonography findings in two main variants of progressive supranuclear palsy

  2013cites this paper
• Behavioural and emotional symptoms of apathy are associated with distinct patterns of brain atrophy in neurodegenerative disorders

  2013cites this paper
• Episodic memory in frontotemporal dementia: a critical review.

  2012cites this paper
• Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementia

  2012cites this paper
• Recent advances in structural MRI in Parkinson’s disease and atypical parkinsonian syndromes

  2012cites this paper
• Nitrous oxide-induced myelopathy with inverted V-sign on spinal MRI

  2012cites this paper
• Diffusion tensor MRI contributes to differentiate Richardson's syndrome from PSP-parkinsonism.

  2012influential citation
• Social cognitive deficits and their neural correlates in progressive supranuclear palsy

  2012cites this paper
• The relationship between clinical and pathological variables in Richardson’s syndrome

  2012influential citation
• In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS

  2012cites this paper
• New insights into atypical parkinsonism.

  2011cites this paper
• Parkinsonism: heterogeneity of a common neurological syndrome.

  2011cites this paper
• Social cognitive deficits and their neural correlates in progressive supranuclear palsy

  year unknowncites this paper